Autonomic Syncope in Pediatrics: A Practice-Oriented Approach to Classification, Pathophysiology, Diagnosis, and Management

Clinical Pediatrics

Volumn 43, Issue 1, 2004, Pages 17-23

  Sapin, Samuel O ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Southern California Permanente Medical Group   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; FLUDROCORTISONE; MIDODRINE; PAROXETINE; PSEUDOEPHEDRINE; SEROTONIN UPTAKE INHIBITOR;

AUTONOMIC SYNCOPE; CENTRAL SYNCOPE; CEREBRAL SYNCOPE; CHILD; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; HUMAN; NEUROCARDIOGENIC SYNCOPE; PATHOPHYSIOLOGY; PATIENT EDUCATION; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; REFLEX SYNCOPE; REVIEW; SIDE EFFECT; SITUATIONAL SYNCOPE; SYNCOPE;

ADOLESCENT; AUTONOMIC NERVOUS SYSTEM; CHILD; HUMANS; SYNCOPE;

EID: 1642499254     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/000992280404300103     Document Type: Review

References (22)

1. Driscoll DJ, Jacobsen SJ, Porter CJ, Wollan PC. Syncope in children and adolescents. J Am Coll Cardiol. 1997;29:1039-1045.
2. Brignole M, Alboni P, Benditt D, et al. Task Force on Syncope: guidelines on management (diagnosis and treatment of syncope). Eur Heart J. 2001;22:1256-1306.
3. Grubb BP. Pathophysiology and differential diagnosis of neurocardiogenic syncope. Am J Cardiol. 1999;84 (8A):3Q-9Q.
4. Johnsrude C. Current approach to pediatric syncope. Pediatr Cardiol. 2000;21:522-531.
5. Mosqueda-Garcia R, Furlan R, Tank J, Fernandez-Violante R. The elusive pathophysiology of neurally mediated syncope. Circulation. 2000;102:2898-2906.
6. Moak JP, Bailey JJ, Makhlouf FT. Simultaneous heart rate and blood pressure variability analysis: insight into mechanisms underlying neurally mediated cardiac syncope in children. J Am Coll Cardiol. 2002;40:1466-1474.
7. Flevari PP, Livanis EG, Theodorakis GN, et al. Baroreflexes in vasovagal syncope: two types of abnormal response. PACE. 2002;25:1315-1323.
8. Mercader MA, Varghese PJ, Potolicchio SJ, et al. New insights into the mechanism of neurally mediated syncope. Heart. 2002;88:217-221.
9. Hainsworth R. Syncope: what is the trigger? Heart. 2003;89:123-124.
10. Julu POO, Cooper VL, Hansen S, Hainsworth R. Cardiovascular regulation in the period preceding vasovagal syncope in conscious humans. J Physiol. 2003; online as 10.1113/jphysiol.2002.036715.
11. Ritter S, Tani LY, Etheridge SP, et al. What is the yield of screening echocardiography in pediatric syncope? Pediatrics. 2000;105:1147.
12. Levine MM. Neurally mediated syncope in children: results of tilt testing, treatment, and long-term follow-up. Pediatr Cardiol. 1999;20:331-335.
13. Kapoor WN. Is there an effective treatment for neurally mediated syncope? JAMA. 2003;289:2272-2274.
14. Kouakam C, Vaksmann G, Pachy E, et al. Long-term follow-up of children and adolescents with syncope: predictor of recurrence. Eur Heart J. 2001;22:1618-1625.
15. Calkins H. Pharmacologic approaches to therapy for vasovagal syncope. Am J Cardiol. 1999;84(8A):20Q-25Q.
16. McLeod KA, Wilson N, Hewitt J, et al. Cardiac pacing for severe childhood neurally mediated syncope with reflex anoxic seizures. Heart. 1999;82:721-725.
17. Eichna LW, Horvath SM, Bean WB. Post-exertional orthostatic hypotension. Am J Med Sci. 1949;213:641-654.
18. Rodriguez-Nunez A, Fernandez-Cebrian S, Perez-Munuzuri P, et al. Cerebral syncope in children. J Pediatr. 2000;136:542-554.
19. Vincent S, Robertson D. The broader view: catecholamine abnormalities. Clin Auton Res. 2002;12(Suppl 1): 1/44-1/49.
20. Karas B, Grubb BP, Boehm K, Kip K. The postural orthostatic tachycardia syndrome: a potentially treatable cause of chronic fatigue, exercise intolerance, and cognitive impairment in adolescents. PACE. 2000;23:344-351.
21. Goldstein DS, Holmes C, Frank SM, et al. Cardiac sympathetic dysautonomia in chronic orthostatic intolerance syndromes. Circulation. 2002;106:2358-2365.
22. Narita N, Narita M, Takashima S, et al. Serotonin transporter gene variation is a risk factor for sudden infant death syndrome in the Japanese population. Pediatrics. 2001;107:690-692.